SAN FRANCISCO—To reinvigorate medical innovation, the U.S. is in “desperate need of governmental and regulatory reform” and positive case examples to show that it still can be achieved, according to Martin B. Leon, MD, who gave a Nov. 7 lecture at the 23rd annual Transcatheter Cardiovascular Therapeutics (TCT) conference.
Leon, who is director of the Center for Interventional Vascular Therapy at New York-Presbyterian Hospital/Columbia University Medical Center in New York City, defined innovation as a novelty that creates value, and medical innovation as “progress in technology usually resulting less from individual genius and more from collective effort and social, political and economic forces that come together to create an ecosystem which fosters innovation.”
To read the full, original article click on this link: TCT: Regulatory process, costs drive medical innovation out of the U.S.
